Ptc Therapeutics (PTCT) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $15.9 million.
- Ptc Therapeutics' Profit After Tax rose 11490.43% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $751.7 million, marking a year-over-year increase of 26586.97%. This contributed to the annual value of -$363.3 million for FY2024, which is 4202.16% up from last year.
- Latest data reveals that Ptc Therapeutics reported Profit After Tax of $15.9 million as of Q3 2025, which was up 11490.43% from -$64.8 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Profit After Tax ranged from a high of $866.6 million in Q1 2025 and a low of -$198.9 million during Q2 2023
- In the last 5 years, Ptc Therapeutics' Profit After Tax had a median value of -$126.7 million in 2022 and averaged -$66.1 million.
- As far as peak fluctuations go, Ptc Therapeutics' Profit After Tax tumbled by 9173.51% in 2021, and later soared by 104627.63% in 2025.
- Over the past 5 years, Ptc Therapeutics' Profit After Tax (Quarter) stood at -$143.3 million in 2021, then dropped by 19.28% to -$170.9 million in 2022, then rose by 8.83% to -$155.8 million in 2023, then surged by 57.71% to -$65.9 million in 2024, then skyrocketed by 124.13% to $15.9 million in 2025.
- Its last three reported values are $15.9 million in Q3 2025, -$64.8 million for Q2 2025, and $866.6 million during Q1 2025.